NUCLEIC ACID INSIGHTS

Filter by ContentType

Is the literature review paper dead? How AI is transforming the research landscape in DNA research

Is the literature review paper dead? How AI is transforming the research landscape in DNA research

Jon Ashley
27 January 2025
Viewpoint
Advancing mRNA-based cell therapies: the crucial role of mRNA optimization for therapeutic efficacy

Advancing mRNA-based cell therapies: the crucial role of mRNA optimization for therapeutic efficacy

Christian Bär, Ulrich Blache, Sandy Tretbar
23 January 2025
Viewpoint
Navigating the mRNA-LNP patent labyrinth: advice for developers

Navigating the mRNA-LNP patent labyrinth: advice for developers

Dan Shores
07 November 2024
Viewpoint
History is the best teacher: what can RNA manufacturers learn from the challenges and successes of traditional biologics?

History is the best teacher: what can RNA manufacturers learn from the challenges and successes of traditional biologics?

Adam Brown
01 November 2024
Viewpoint
Potential use of lipid nanoparticles in non-vaccine therapeutics

Potential use of lipid nanoparticles in non-vaccine therapeutics

Nagy Habib
22 October 2024
Viewpoint
Revolutionizing in vivo genome editing with targeted, non-viral delivery

Revolutionizing in vivo genome editing with targeted, non-viral delivery

Joseph Nabhan, Gary Hao, Qin Yu
11 September 2024
Viewpoint
Delivering on the next generation of oligo therapies depends on overcoming, not ignoring, that sequence and chemistry are separable, but not independent

Delivering on the next generation of oligo therapies depends on overcoming, not ignoring, that sequence and chemistry are separable, but not independent

Chris Hart
08 August 2024
Viewpoint
Expanding the therapeutic index of lipid nanoparticles: potential key for clinical translation success

Expanding the therapeutic index of lipid nanoparticles: potential key for clinical translation success

Zhenghong Gao
12 June 2024
Viewpoint
Regulatory strategies for developing and manufacturing RNA-LNPs

Regulatory strategies for developing and manufacturing RNA-LNPs

Alexander Aust
05 April 2024
Viewpoint
Human capital comes with a memory

Human capital comes with a memory

Helena Strigard
25 March 2024
Viewpoint
Glimpsing the future of siRNA delivery strategies and the broader therapeutic application of oligonucleotides

Glimpsing the future of siRNA delivery strategies and the broader therapeutic application of oligonucleotides

Naim Nazef
12 March 2024
Viewpoint
A brave new world of next-generation DNA applications in the biotherapeutics field

A brave new world of next-generation DNA applications in the biotherapeutics field

Floris Engelhardt
23 February 2024
Viewpoint
The evolving realm of nucleic acids: past, present, and future

The evolving realm of nucleic acids: past, present, and future

Chris Mason
22 February 2024
Viewpoint
Shaping immunity against infectious diseases with multivalent DNA vaccines

Shaping immunity against infectious diseases with multivalent DNA vaccines

Ami Patel
15 February 2024
Viewpoint
Expanding horizons with mRNA vaccines against bacteria

Expanding horizons with mRNA vaccines against bacteria

Nicholas K Clark, Leah Cole
23 April 2023
Viewpoint
Opportunities and challenges in mRNA-LNP vaccine design

Opportunities and challenges in mRNA-LNP vaccine design

Rein Verbeke, Pieter R Cullis
17 April 2023
Viewpoint
Developing mRNA vaccines for malaria elimination

Developing mRNA vaccines for malaria elimination

Nirbhay Kumar
11 April 2023
Viewpoint
What’s next for mRNA vaccines?

What’s next for mRNA vaccines?

Jeffrey Ulmer
10 April 2023
Viewpoint
Exploring the potential of circular RNA

Exploring the potential of circular RNA

Piotr Kowalski
23 January 2023
Viewpoint
A bright future for lipid nanoparticles in gene therapy

A bright future for lipid nanoparticles in gene therapy

Hongwei Zhang
09 July 2021
Viewpoint